SuspendedNCT04322305
Pregabalin Trial for the Treatment of Addiction
Researchers are comparing Pregabalin and placebo to find out how the approaches affect alcohol use in people with alcohol dependence.
Medication studyAges 18–65United States
Understand this study
What is this study about?
Researchers are comparing Pregabalin and placebo to find out how the approaches affect alcohol use in people with alcohol dependence.
Who could participate?
Listed age limits: 18 years to 65 years.
- Listed locations
- New YorkSee all locations and recruitment
- Study phase
- Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.
What to know before participating
A point to clarify
This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?
Things to check before joining
Study start dateStarted: January 11, 2021
- Recruitment status
- Suspended
- Enrollment listed in the registry
- 50
- Sponsor
- New York State Psychiatric Institute
- Sponsor type
- Research institute
- Study type
- Drug
- Intervention type
- Medication / drug, OTHER
- Study phase
- Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.
- Locations
- United States
- Age range
- From 18 Years to 65 Years
- Official registry ID
- NCT04322305
- Official title
Show the full official title
A Double-blind, Placebo-Controlled Trial of Pregabalin for the Treatment of Alcohol Use Disorder
Recruitment & locations
SuspendedNew York
A listed location does not confirm current availability.
Questions about this study
What is this study about?
Researchers are comparing Pregabalin and placebo to find out how the approaches affect alcohol use in people with alcohol dependence.
Who is behind this study?
The study sponsor is New York State Psychiatric Institute, a research institute.
Does this study involve medication?
Yes. The study involves medication, including Pregabalin.
Who can participate?
Listed age limits: 18 years to 65 years.
Is this study still recruiting?
The registry lists this study as suspended.
